Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1541-1550

  Kim, Sangmin ^a   Oh, Soo Jin ^a   Lee, Jeongmin ^a   Han, Jeonghun ^a   Jeon, Myeongjin ^a   Jung, Taewoo ^a   Lee, Se Kyung ^a   Bae, Soo Youn ^a   Kim, Jiyoung ^a   Gil, Won Ho ^a   Kim, Seok Won ^a   Lee, Jeong Eon ^a   Nam, Seok Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

AKT; Berberine; Fibronectin; PI 3K; VEGF

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BERBERINE; FIBRONECTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOVIRIDAE;

BERBERINE; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FIBRONECTINS; HUMANS; MCF-7 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890731254     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356591     Document Type: Article

References (41)

1. Harris JR, Lippman ME, Veronesi U, Willett W: Breast cancer (1). N Engl J Med 1992;327:319-328.
2. Rabbani SA, Mazar AP: Evaluating distant metastases in breast cancer: From biology to outcomes. Cancer Metastasis Rev 2007;26:663-674.
3. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
4. Zeisberg M, Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009;119:1429-1437.
5. Ikram M: A review on the chemical and pharmacological aspects of genus berberis. Planta Med 1975;28:353-358.
6. Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y, Shao C: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 2009;662:75-83.
7. Kim JB, Lee KM, Ko E, Han W, Lee JE, Shin I, Bae JY, Kim S, Noh DY: Berberine inhibits growth of the breast cancer cell lines mcf-7 and mda-mb-231. Planta Med 2008;74:39-42.
8. Kim S, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ: Berberine suppresses the tpa-induced mmp-1 and mmp-9 expressions through the inhibition of pkc-alpha in breast cancer cells. J Surg Res 2012;176:e21-29.
9. Lin JP, Yang JS, Wu CC, Lin SS, Hsieh WT, Lin ML, Yu FS, Yu CS, Chen GW, Chang YH, Chung JG: Berberine induced down-regulation of matrix metalloproteinase-1,-2 and-9 in human gastric cancer cells (snu-5) in vitro. In Vivo 2008;22:223-230.
10. Kim S, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE: Berberine suppresses tnf-alpha-induced mmp-9 and cell invasion through inhibition of ap-1 activity in mda-mb-231 human breast cancer cells. Molecules 2008;13:2975-2985.
11. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
12. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
13. Ferrara N: Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 2004;9 Suppl 1:2-10.
14. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
15. Hicklin DJ, Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-1027.
16. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-969.
17. Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H: Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 2001;12:129-135.
18. Hsiong SX, Huebsch N, Fischbach C, Kong HJ, Mooney DJ: Integrin-adhesion ligand bond formation of preosteoblasts and stem cells in three-dimensional rgd presenting matrices. Biomacromolecules 2008;9:1843-1851.
19. Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature 2008;454:436-444.
20. Chao YL, Shepard CR, Wells A: Breast carcinoma cells re-express e-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 2010;9:179.
21. Christensen L: The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS Suppl 1992;26:1-39.
22. Hodges RR, Kazlauskas A, Toker A, Dartt DA: Effect of overexpression of protein kinase c alpha on rat lacrimal gland protein secretion. Adv Exp Med Biol 2002;506:237-241.
23. Shimao Y, Nabeshima K, Inoue T, Koono M: Tpa-enhanced motility and invasion in a highly metastatic variant (l-10) of human rectal adenocarcinoma cell line rcm-1: Selective role of pkc-alpha and its inhibition by a combination of pdbu-induced pkc downregulation and antisense oligonucleotides treatment. Clin Exp Metastasis 1999;17:351-360.
24. Schlingemann J, Hess J, Wrobel G, Breitenbach U, Gebhardt C, Steinlein P, Kramer H, Furstenberger G, Hahn M, Angel P, Lichter P: Profile of gene expression induced by the tumour promotor tpa in murine epithelial cells. Int J Cancer 2003;104:699-708.
25. Segal A, Van Duuren BL, Mate U: The identification of phorbolol myristate acetate as a new metabolite of phorbol myristate acetate in mouse skin. Cancer Res 1975;35:2154-2159.
26. Silinsky EM, Searl TJ: Phorbol esters and neurotransmitter release: More than just protein kinase c? Br J Pharmacol 2003;138:1191-1201.
27. Clemens MJ, Trayner I, Menaya J: The role of protein kinase c isoenzymes in the regulation of cell proliferation and differentiation. J Cell Sci 1992;103:881-887.
28. Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE: Silibinin prevents tpa-induced mmp-9 expression and vegf secretion by inactivation of the raf/mek/erk pathway in mcf-7 human breast cancer cells. Phytomedicine 2009;16:573-580.
29. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, Venitz J, Figg WD: The role of vascular endothelial growth factor snps as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 2009;8:2496-2508.
30. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP: Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996;56:2013-2016.
31. Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K: The role of angiogenesis in solid tumours: An overview. Eur J Intern Med 2009;20:663-671.
32. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL: Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998;51:161-167.
33. Yamaguchi T, Bando H, Mori T, Takahashi K, Matsumoto H, Yasutome M, Weich H, Toi M: Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis. Cancer Sci 2007;98:405-410.
34. Loureiro RM, D'Amore PA: Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005;16:77-89.
35. Abdelrahim M, Smith R 3rd, Burghardt R, Safe S: Role of sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 2004;64:6740-6749.
36. Gille J, Swerlick RA, Caughman SW: Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (vpf/vegf) gene requires ap-2-dependent DNA binding and transactivation. EMBO J 1997;16:750-759.
37. Porntadavity S, Xu Y, Kiningham K, Rangnekar VM, Prachayasittikul V, St Clair DK: Tpa-activated transcription of the human mnsod gene: Role of transcription factors sp-1 and egr-1. DNA Cell Biol 2001;20:473-481.
38. Helleman J, Jansen MP, Ruigrok-Ritstier K, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Klijn JG, Sleijfer S, Foekens JA, Berns EM: Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response. Clin Cancer Res 2008;14:5555-5564.
39. Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY, Fu SB: Characterisation of fibronectin-mediated fak signalling pathways in lung cancer cell migration and invasion. Br J Cancer 2009;101:327-334.
40. Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dorken B, Bargou RC: Pi3-k/akt/fkhr and mapk signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 2004;18:1883-1890.
41. Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, Krymskaya VP, Lazaar AL: Vascular endothelial growth factor-induced secretion of fibronectin is erk dependent. Am J Physiol Lung Cell Mol Physiol 2004;286:L539-545.